Doctor profile · Federal record
Dr. Kyle Brownback, MD
Pulmonary Disease Physician (CMS: Pulmonary Disease) · Internal Medicine Physician · Critical Care Medicine (Internal Medicine) Physician · Kansas City, KS
- NPI 1619192291
- Accepts Medicare
- MIPS 87.6 / 100 · 2023
- 20 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3901 Rainbow Blvd
Kansas City, KS 661608500
(913) 588-5000
fax (913) 588-4098 - Mailing address
-
4000 Cambridge St
Kansas City, KS 661608501
Credentials & registration
- NPI registered
- April 2007 — 19 yrs on file
- Profile last updated
- November 2, 2023
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State licenses (2)
- Kansas #04-34217 · Rhode Island #LP008845
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1619192291. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,006
Distinct HCPCS
10
Medicare allowed
$74,515
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
94010 |
Test to measure expiratory airflow and volume | 143 | 134 | $8 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 137 | 65 | $114 | |
94729 |
Test to examine how well the lungs exchange gases | 134 | 133 | $8 | |
99291 |
Critical care, first 30-74 minutes | 127 | 49 | $203 | |
94726 |
Test to determine lung volumes using sensors | 111 | 111 | $11 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 90 | 83 | $92 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 60 | 41 | $136 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 41 | 41 | $10 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 36 | 22 | $75 | |
99292 |
Critical care, each additional 30 minutes | 33 | 15 | $102 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 56. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$13,211
Transactions
10
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 8 | $12,461.28 | |
| AstraZeneca Pharmaceuticals LP | 1 | $525.00 | |
| Ambu A/S | 1 | $225.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
459
Patients
107
Total drug cost
$443,368
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 69 | 13 | $54,461 |
| Montelukast Sodium | Generic | 61 | 18 | $864 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 61 | 21 | $38,248 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 54 | 25 | $2,352 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 40 | 13 | $39,104 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 26 | 0 | $17,002 |
| Prednisone | Generic | 26 | 17 | $125 |
| Advair Hfa (Fluticasone Propion/Salmeterol) | Brand | 20 | 0 | $13,840 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 20 | 0 | $10,915 |
| Azithromycin | Generic | 17 | 0 | $188 |
Hospital affiliations
Frequently asked questions
What is Dr. Kyle Brownback's medical specialty?
Dr. Kyle Brownback practices Pulmonary Disease Physician in Kansas City, KS.
Where does Dr. Kyle Brownback practice?
Dr. Kyle Brownback practices at 3901 Rainbow Blvd, Kansas City, KS 661608500. Office phone: 9135885000.
What is Dr. Kyle Brownback's NPI?
Dr. Kyle Brownback's National Provider Identifier (NPI) is 1619192291, issued by NPPES.
Does Dr. Kyle Brownback accept Medicare assignment?
Yes. Dr. Kyle Brownback accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kyle Brownback commonly perform?
Top Medicare-reported procedures in 2023: Test to measure expiratory airflow and volume (HCPCS 94010); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Test to examine how well the lungs exchange gases (HCPCS 94729). Source: CMS Medicare Physician & Other Practitioners file.